Literature DB >> 10358027

High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan.

L Goretzki1, M A Burg, K A Grako, W B Stallcup.   

Abstract

NG2 is a transmembrane chondroitin sulfate proteoglycan that is expressed by immature progenitor cells in several developmental lineages and by some types of malignant cells. In vitro studies have suggested that NG2 participates in growth factor activation of the platelet-derived growth factor-alpha receptor. In this study the ability of recombinant NG2 core protein to interact with several different growth factors (epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF)-AA, PDGF-BB, vascular endothelial growth factor (VEGF)165 and transforming growth factor (TGF)-beta1) was investigated using two different assay systems: enzyme-linked immunosorbent assay-type solid-phase binding and an optical biosensor (BIAcore) system. High-affinity binding of bFGF and PDGF-AA to the core protein of NG2 could be demonstrated with both types of assays. Using both the BIAcore software analysis program and nonlinear regression analysis of the solid phase binding data, KD values in the low nanomolar range were obtained for binding of each of these growth factors to NG2. The results further indicate that NG2 contains at least two binding sites for each of these two growth factors. PDGF-BB, TGF-beta1, VEGF, and EGF exhibited little or no binding to NG2 in either type of assay. These data suggest that NG2 can have an important role in organizing and presenting some types of mitogenic growth factors at the cell surface.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10358027     DOI: 10.1074/jbc.274.24.16831

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors.

Authors:  Leonard L Jones; Yu Yamaguchi; William B Stallcup; Mark H Tuszynski
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

2.  The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2.

Authors:  D S Barritt; M T Pearn; A H Zisch; S S Lee; R T Javier; E B Pasquale; W B Stallcup
Journal:  J Cell Biochem       Date:  2000-08-02       Impact factor: 4.429

Review 3.  Roles of NG2 glial cells in diseases of the central nervous system.

Authors:  Jian-Ping Xu; Jie Zhao; Shao Li
Journal:  Neurosci Bull       Date:  2011-12       Impact factor: 5.203

4.  Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.

Authors:  Ugur Ozerdem; William B Stallcup
Journal:  Angiogenesis       Date:  2004       Impact factor: 9.596

Review 5.  NG2-expressing cells in the nervous system: role of the proteoglycan in migration and glial-neuron interaction.

Authors:  Khalad Karram; Nivedita Chatterjee; Jacqueline Trotter
Journal:  J Anat       Date:  2005-12       Impact factor: 2.610

6.  Immunohistochemical study of NG2 chondroitin sulfate proteoglycan expression in the small and large intestines.

Authors:  Nobuo Terada; Nobuhiko Ohno; Shinichi Murata; Ryohei Katoh; William B Stallcup; Shinichi Ohno
Journal:  Histochem Cell Biol       Date:  2006-04-20       Impact factor: 4.304

7.  NG2 proteoglycan expression in mouse skin: altered postnatal skin development in the NG2 null mouse.

Authors:  Kuniko Kadoya; Jun-Ichi Fukushi; Yoshihiro Matsumoto; Yu Yamaguchi; William B Stallcup
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

Review 8.  NG2: a component of the glial scar that inhibits axon growth.

Authors:  Andrew M Tan; Weibing Zhang; Joel M Levine
Journal:  J Anat       Date:  2005-12       Impact factor: 2.610

Review 9.  Pericyte dynamics during angiogenesis: new insights from new identities.

Authors:  Peter C Stapor; Richard S Sweat; Derek C Dashti; Aline M Betancourt; Walter Lee Murfee
Journal:  J Vasc Res       Date:  2014-05-17       Impact factor: 1.934

10.  Differential binding of platelet-derived growth factor isoforms to glycosaminoglycans.

Authors:  Raquel García-Olivas; Johan Hoebeke; Susanna Castel; Manuel Reina; Gunnar Fager; Florentina Lustig; Senén Vilaró
Journal:  Histochem Cell Biol       Date:  2003-10-14       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.